TORONTO, April 27, 2018 /PRNewswire/ – Cronos Group Inc. (NASDAQ, TSX-V: CRON) ("Cronos Group" or the "Company")will release its financial results for the fourth quarter and fiscal year ended December 31, 2017 before the market opens on April 30, 2018.
Conference CallThe Company will host
Conference ID: 7294557Topic: Cronos Group Inc. Earnings CallToll-free dial-in number: (888) 231-8191International dial-in number: (647) 427-7450
Additionally, an audio replay of the conference call will be available two hours after the call's completion and until 11:59 p.m. EST on May 14, 2018. Instructions for the audio replay are provided below:
Toll-free dial-in number: (855) 859-2056Passcode: 7294557
About Cronos GroupCronos Group is a globally diversified and vertically integrated cannabis company with a presence across four continents. The Company operates two wholly-owned Canadian licensed producers regulated under Health Canada's Access to Cannabis for Medical Purposes Regulations: Peace Naturals Project Inc., which was the first non-incumbent medical cannabis license granted by Health Canada and Original BC Ltd. (British Columbia), which is based in the Okanagan Valley. The Company has multiple international production and distribution platforms including Germany, Israel and Australia. The Company is rapidly expanding its global footprint as it focuses on building an international iconic brand portfolio and developing disruptive intellectual property. Cronos Group is committed to building industry leading companies that transform the perception of cannabis and responsibly elevate the consumer experience.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
View original content with multimedia:http://www.prnewswire.com/news-releases/cronos-group-inc-to-hold-conference-call-on-fourth-quarter-and-fiscal-year-2017-financial-results-300637876.html
SOURCE Cronos Group Inc.
Subscribe to our Free Newsletters!
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...
Stereotypic movement disorder (SMD) is a motor disorder, associated with neurodevelopmental ...View All